Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2010
07/06/2010US7749697 Method for linking sequences of interest
07/06/2010US7749696 Using single fragment length polymorphism in nitrate reductase operon/promoter as screening tool in detection of mycobacterium tuberculosis
07/06/2010US7749695 Using protein profiles aspredictive tools in prognosis and treatment of immune related disorders
07/06/2010US7749694 Providing class of binding proteins with a range of binding specificities and affinities based upon variation at select amino acid positions within a scaffold; no conformational shifts in the hemagglutinin folds
07/06/2010US7749506 Envelope protein for use as immunization tool in treatment and prevention of viral disease in crustaceans
07/06/2010US7749505 Immunogenic polypeptides for use in targeted treatment and prevention of cell proliferative disorders associated with respiratory system
07/06/2010US7749500 Antibodies to IL-17 polypeptides and therapeutic uses thereof
07/06/2010US7749499 Immunoglobulin for use in diagnosis, prevention and treatment of neisserial infection; immunootherapeutics
07/06/2010US7749494 Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders
07/06/2010US7749491 Contacting the mammalian cell with at least one adeno-associated virus (rAAV) and at least two agents in an amount effective to additively or synergistically enhance rAAV transduction
07/06/2010CA2522067C Detection, characterization and treatment of viral infection and methods thereof
07/06/2010CA2477433C Methods and materials for detecting genetic material
07/06/2010CA2461199C Atlastin
07/06/2010CA2406581C Assay device with timer function
07/06/2010CA2391425C Transition metal complexes with bidentate ligand having an imidazole ring
07/06/2010CA2378408C Polynucleotide amplification method
07/06/2010CA2363537C Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods
07/06/2010CA2328750C Thermally conductive sensor
07/06/2010CA2318354C Biomarkers and targets for diagnosis, prognosis and management of prostate disease
07/06/2010CA2225547C Apparatus for the parallel alignment of macromolecules, and use thereof
07/06/2010CA2209360C Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen
07/06/2010CA2162729C Cloning and recombinant production of crf (corticotropin releasing factor) receptor(s)
07/06/2010CA2123049C Pharmaceutical containing the p40 subunit of interleukin 12
07/01/2010WO2010075579A2 Methods of predicting medically refractive ulcerative colitis (mr-uc) requiring colectomy
07/01/2010WO2010075570A2 Methods, computer-accessible medium, and systems for score-driven whole-genome shotgun sequence assemble
07/01/2010WO2010075527A2 Method of dna sequencing
07/01/2010WO2010075519A2 Allelic variants associated with advanced age-related macular degeneration
07/01/2010WO2010075510A2 Large scale pancreatic islet purification
07/01/2010WO2010075459A1 Methods and genotyping panels for detecting alleles, genomes, and transcriptomes
07/01/2010WO2010075441A1 Modular nucleic acid-based circuits for counters, binary operations, memory, and logic
07/01/2010WO2010075414A2 Method for detection of xmrv
07/01/2010WO2010075413A1 Monochrome multiplex quantitative pcr
07/01/2010WO2010075375A1 Compositions, methods and related uses for cleaving modified dna
07/01/2010WO2010075360A2 Methods for detection of sepsis
07/01/2010WO2010075188A2 Multibase delivery for long reads in sequencing by synthesis protocols
07/01/2010WO2010075176A1 Methods for detecting tcr-gamma gene rearrangement
07/01/2010WO2010075175A1 Mass spectrometry assay for estrogenic compounds
07/01/2010WO2010075044A1 Mass spectrometry assay for thiopurine-s-methyl transferase activity and products generated thereby
07/01/2010WO2010075009A2 Diagnostic system for selecting nutrition and pharmacological products for animals
07/01/2010WO2010075007A2 Determining nutrients for animals through gene expression
07/01/2010WO2010074924A1 Identification and regulation of a novel dna demethylase system
07/01/2010WO2010074859A2 Yeast-based methods of identifying nucleic acids and compounds for treating neurodegenerative diseases
07/01/2010WO2010074758A2 Compositions for promoting epigenetic dna demethylation and methods of use therefore
07/01/2010WO2010074573A1 Methods and means for typing a sample comprising colorectal cancer cells.
07/01/2010WO2010074450A9 Lc-mfr-ms-based method and apparatus for screening a new drug candidate
07/01/2010WO2010074450A2 Lc-mfr-ms-based method and apparatus for screening a new drug candidate
07/01/2010WO2010074266A1 Anti-cd4 antibody
07/01/2010WO2010074241A1 Method for predicting therapeutic effect of combination chemotherapy
07/01/2010WO2010074240A1 Method for predicting therapeutic effect of chemotherapy
07/01/2010WO2010074080A1 Expression vector for producing protein derived from foreign gene in large quantity using animal cells, and use thereof
07/01/2010WO2010073760A1 Method for evaluation of differentiation ability of stem cell
07/01/2010WO2010073721A1 Prediction of effectiveness of preoperative chemoradiotherapy on rectal cancer using micro-rna
07/01/2010WO2010073544A1 Method for testing risk of coronary artery diseases
07/01/2010WO2010073415A1 Method for evaluating the culturability of living cells subjected to long-term freeze-storage, and storing and guaranteeing of same
07/01/2010WO2010073407A1 Method for evaluation of differentiation ability of stem cell
07/01/2010WO2010073266A1 Sequence variants predictive of risk of kidney stones and bone mineral density
07/01/2010WO2010073248A2 Gene expression signature for classification of tissue of origin of tumor samples
07/01/2010WO2010073218A2 Methylation biomarkers for predicting relapse free survival
07/01/2010WO2010073015A2 Peptide tag and uses thereof
07/01/2010WO2010073001A1 Biomarker
07/01/2010WO2010072947A1 Novel biotracers and uses thereof for controlling filtration plants
07/01/2010WO2010072895A1 Method and device for detecting micro-organisms from fluid
07/01/2010WO2010072834A1 Nucleic acid purification method
07/01/2010WO2010072767A1 Method for verifying and/or identifying hormonally effective substances
07/01/2010WO2010072752A2 Fluorescent probes
07/01/2010WO2010072608A1 Pcsk1 single nucleotide polymorphism in type 2 diabetes
07/01/2010WO2010072600A1 Polyketide biosynthesis genes
07/01/2010WO2010072389A1 Method for determining the predisposition for crohn's disease
07/01/2010WO2010072366A1 Method for detecting a target nucleic acid in a sample
07/01/2010WO2010072118A1 Probes, liquid phase chips and methods for detecting pik3ca gene mutations
07/01/2010WO2010071983A1 Mutated voltage-gated sodium channel nav alpha subunit for identification of modulators
07/01/2010WO2010071973A1 Modification of plant phenotypes through tor gene expression
07/01/2010WO2010071915A1 Determinants of the acute sickness response
07/01/2010WO2010056709A3 Eimeria vaccine for turkeys
07/01/2010WO2010054156A3 Vaccines targeting cellular death receptors
07/01/2010WO2010045323A3 A novel sorting technology that allows for highly efficient selection of sperm without chromatin damage
07/01/2010WO2010042669A3 Co-culture compositions and methods
07/01/2010WO2010042551A3 Methods for providing cellular lysates from cell wall-containing samples
07/01/2010WO2010039649A3 Flavivirus-based system for production of hepatitis c virus (hcv)
07/01/2010WO2010036795A3 Screening methods for identifying specific staphylococcus aureus inhibitors
07/01/2010WO2010036353A9 Genetic markers for optimizing treatment for schizophrenia
07/01/2010WO2010033825A3 Genetic variants associated with abdominal aortic aneurysms
07/01/2010WO2010033818A3 Mirna targets
07/01/2010WO2010033452A3 Mono-and multi-element coded libs assays and methods
07/01/2010WO2010030980A3 Akt and clusterin as biomarkers of chemotherapeutic responsiveness
07/01/2010WO2010030828A3 Sonication-assisted metal-enhanced fluorescence (samef)-based bioassays
07/01/2010WO2010028288A3 Methods for stratifying and annotating cancer drug treatment options
07/01/2010WO2010027870A3 Assay methods for increased throughput of samples and/or targets
07/01/2010WO2010027497A3 Preparations, compositions, and methods for nucleic acid sequencing
07/01/2010WO2010025420A3 Methods of identifying functional characteristics of promoters, transcription modifying proteins and transcription modulating agents
07/01/2010WO2010023605A3 Method for the identification of genes involved in neurodegenerative processes
07/01/2010WO2010019414A3 Detecting nucleic acid
07/01/2010WO2010008862A3 Live attenuated catfish vaccine and method of making
07/01/2010WO2010007391A3 Hexacyanoferrate modified electrode
07/01/2010WO2009152529A3 Programming and reprogramming of cells
07/01/2010WO2009151407A3 Influenza sequences
07/01/2010WO2009111042A3 Hiv co-receptor tropism assays and compositions thereof
07/01/2010WO2009108917A3 Markers for improved detection of breast cancer
07/01/2010WO2009060210A8 Predictive test for adult dog body size
07/01/2010US20100170006 Methods for screening of novel functions of receptor like kinases